METHODS	The PROMISE-GIM6 ( Prevention of Menopause Induced by Chemotherapy : A Study in Early Breast Cancer Patients-Gruppo Italiano Mammella 6 ) study , a parallel , randomized , open-label , phase 3 superiority trial , was conducted at 16 sites in Italy and enrolled 281 patients between October 2003 and January 2008 .\